1/30/2026

Mesalamine Extended-Release Capsules

Products Affected - Description

- Mesalamine oral capsule, Sun Pharma, 500 mg, bottle, 120 count, NDC 63304-0089-13

Reason for the Shortage

- Sun Pharma did not provide a reason for the shortage.

Available Products

- Pentasa oral capsule, Takeda, 250 mg, bottle, 240 count, NDC 54092-0189-81
- Pentasa oral capsule, Takeda, 500 mg, bottle, 120 count, NDC 54092-0191-12

Estimated Resupply Dates

- Sun Pharma has mesalamine extended-release 500 mg capsules in 120 count bottles on back order and the company cannot estimate a resupply date.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.